Bionyra Pharma
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
$165MSeries A
Role not disclosedActivity from announced rounds
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
Builds AI platform helping pharma companies identify, activate and optimize patient and HCP audiences
Develops therapies for neurodegenerative diseases.